In recent years, several technologies have emerged in the medical aesthetic world. Among these, several tend to satisfy the demand for body contouring, which is defining the contours of the body, while refining and sculpting the silhouette. Hot or cold, there are several options available.
CoolSculpting and VelaShape III, two body contouring technologies offered by Medicart, defines the contours of the body, while refining and sculpting the silhouette.
COOLSCULPTING
This involves a medical aesthetic device that was developed by the company Zeltiq and has been approved by Health Canada since 2013. CoolSculpting is a process based on cold destruction. Through cryolipolysis, fat cells in well-targeted areas destroy themselves. Under the action of controlled cold, these cells crystallize and allow a process
of programmed death to occur. Cryolipolysis does not affect surrounding skin cells, muscles, or nerves. The process freezes fat, thus causing a reduction in body contour. CoolSculpting works long term, from three weeks to three months following the treatment. The body works to make cells disappear through the macrophage cells responsible for removing dead cells.
VELASHAPE III
The VelaShape III technology performs body contouring through a hot technique. It targets unwanted curves to achieve a smooth silhouette while toning the skin. For body contouring, the VelaShape III, a non-invasive device at the cutting-edge of technology, works simulta‑ neously on substance and form. It tightens the existing collagen fibres, promotes blood circulation and targets the atrophy of fat tissues. The treated areas gain in tone and lose volume. Their contours also become better defined. The device combines infrared, radiofrequency, palpating-rolling, and suction for a significantly shorter treatment time and clearly better results. During treatment, light pressure is applied, allowing full contact of the tip with the skin of the treated region. It is a sensation similar to a hot deep-tissue massage.
This article first appeared in the November issue of Medicart’s free web magazine. To subscribe, click here.